Skip to content

EV / sales at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
5.1×-0.9×
Danaher logo
DanaherDHR
-0.8×
Bruker logo
BrukerBRKR
-0.4×
Revvity logo
RevvityRVTY
4.4×-0.9×
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
3.1×+0.1×
Agilent Technologies logo
Agilent TechnologiesA
4.8×-0.2×

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$9.07B-11.8%
Enterprise value$9.15B-13.6%
P/E60.6×+13.6×
P/S7.5×-1.0×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Calculated from Bio-Techne’s reported figures.

Based on the most recent quarter.

The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Techne's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Techne's EV / sales?
Bio-Techne (TECH) reported EV / sales of 6.8× in Q1 2026.
How has Bio-Techne's EV / sales changed year-over-year?
Bio-Techne's EV / sales decreased by 13.7% year-over-year, from 7.9× to 6.8×.
What is the long-term trend for Bio-Techne's EV / sales?
Over 4 years (2021 to 2025), Bio-Techne's EV / sales has grown at a -23.3% compound annual growth rate (CAGR), from 19.2× to 6.7×.
What does EV / sales mean?
What the whole business costs relative to its annual sales.
How do you interpret EV / sales?
A fallback valuation gauge for pre-profit or cyclical firms. Like P/S, only comparable across similar-margin businesses, but it accounts for debt and cash unlike P/S.
How does EV / sales compare across companies?
Compare within a margin cohort; the debt-and-cash adjustment makes it cleaner than P/S for leveraged firms.